このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

ファンコア(子供向け体幹安定化)エクササイズが痙直型脳性麻痺児のバランスと機能的移動能力に及ぼす影響

2026年9月17日 更新者:Berk Korkut、Istanbul University

痙直型脳性麻痺児におけるバランスと機能的移動性に対するFun-Core(子ども向け体幹安定化)エクササイズの効果:単盲検ランダム化比較試験

A total of 54 children, aged between 6 and 12 years, diagnosed with hemiplegic cerebral palsy and not meeting the exclusion criteria, who registered at the outpatient clinics of the Department of Physical Medicine and Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, between June 1, 2025 and March 1, 2026, were planned to be included in our thesis study, which was planned to be prospective, randomized and single-blind. Children and their parents will be informed verbally and in writing about the study's purpose, duration, and method of implementation, and their informed consent will be obtained. They will be asked to sign an "Informed Consent Form." Patient assessment and follow-up forms will be completed at pre- and post-treatment follow-ups. Patients who meet the inclusion criteria will be numbered according to their order of admission and then randomly assigned to either the intervention or control groups by a computer program.

In addition to a brochure showing the number of sets and repetitions to be given to the patients as a standard home exercise program, the Fun-Core video exercise program, designed as a child-friendly core stabilization exercise program to be performed 3 times a week, will be given to the intervention group (G1), and the exercises will be delivered to the participants through a website with special accounts.

The control group (G2) will receive a standard home exercise program in brochure format, showing the number of sets and repetitions. The exercise program will be performed at home three times a week for 8 weeks.

調査の概要

研究の種類

介入

入学 (実際)

54

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Fatih
      • Istanbul、Fatih、トルコ(Türkiye)
        • Istanbul Unıversity, Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

6年~12年 (子)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Children with hemiplegic cerebral palsy between the ages of 6 and 12
  • Children with Gross Motor Function Classification System (GMFCS) Levels 1, 2, and 3
  • Shoe sizes 30 and above

Exclusion Criteria:

  • Cognitive impairments that prevent understanding and performing simple commands and tasks
  • Botulinum toxin injections into the upper and/or lower extremities within the last 6 months
  • History of lower extremity or lumbar surgery within the last year
  • Presence of uncontrolled severe epileptic seizures
  • Presence of severe vision or hearing problems
  • Presence of fixed contractures in the lower extremities

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Intervention Group (G1)

In addition to a brochure showing the number of sets and repetitions to be given to the patients as a standard home exercise program, the Fun-Core video exercise program, designed as a child-friendly core stabilization exercise program to be performed 3 times a week, will be given to the intervention group (G1), and the exercises will be delivered to the participants through a website with special accounts.

Fun-Core Exercises will be narrated, prepared and recorded in video format, and then delivered in order to ensure children's development and motivation.

Standard home based exercise program

他の:Control Group (G2)

Standard home exercise program (brochure)

Fun-Core Exercises will be narrated, prepared and recorded in video format, and then delivered in order to ensure children's development and motivation.

Standard home based exercise program

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Modified Timed Up & Go Test
時間枠:Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

The mTUG test is a modified version of the Timed Up and Go (TUG) test for assessing functional mobility in children. It essentially measures how quickly an individual can perform the skills necessary for daily living activities-sitting, standing, walking, turning, and sitting down again. Unlike the standard TUG test, it includes instructions and environmental conditions tailored to the developmental level and cognitive capacity of children. In our study, the mTUG test will be administered to participants wearing shoes equipped with wearable sensors, and the test duration will be measured through the shoes.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

二次結果の測定

結果測定
メジャーの説明
時間枠
Six Minute Walk Test
時間枠:Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

It is considered a measurement that assesses an individual's overall functional status. The test assesses the integrated response of respiratory, cardiovascular, skeletal, nervous, and muscular components. A 30-meter track will be used for the test. The total distance walked by the participant over 6 minutes will be recorded in meters. In our study, the 6-minute walk test will be administered to participants wearing shoes equipped with wearable sensors, and the test will be measured through the shoe.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
Pediatric Balance Scale
時間枠:Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

It will be used to assess balance in children. It consists of 14 items, each item being scored from 0 to 4. The maximum score is 56. The higher the score, the better the child's balance. 1.sitting to standing 2.standing to sitting 3.transfers 4.standing unsupported 5.sitting unsupported 6.standing with eyes closed 7.standing with feet together 8.standing with one foot in front 9.standing on one foot 10.turning 360 degrees 11.turning to look behind 12.retrieving object from floor 13.placing alternate foot on stool 14.reaching forward with outstretched arm

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
Trunk Endurance Tests
時間枠:Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

Performance assessment is conducted by recording the maximum time the individual can maintain the test position. Before each test, the child is asked to maintain the test position for as long as possible. Each test will be repeated three times, and the average time will be recorded. To minimize the risk of injury or psychological distress, the tests will be explained in detail to the children beforehand, and their administration will be demonstrated. Two healthcare professionals will be present during each test to ensure the child maintains proper form and ensure safety.

Back extension test: Biering-Sørensen position with trunk held horizontal, pelvis/legs strapped; ended at loss of position or 300s.

Lateral torso test: Full side-bridge with straight body on elbow; stopped when posture broke or 300s.

Flexor test: Sit-up at 50° support, arms crossed, feet secured; ended when back touched support or 300s.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
Pediatric Reach Test
時間枠:Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

It is a measurement method that evaluates the dynamic component of balance. The test will be conducted by measuring the distance in centimeters that participants can reach forward, then to the right and left, without lifting their heels while standing upright. The procedures will be explained to participants once, and then they will be asked to perform the exercise three times. They will be expected to hold each position for at least 3 seconds. Measurements where participants lose their balance and lift their feet off the ground will be invalid. The distance reached will be measured in centimeters using a non-stretchable tape measure.

The test consists of two sections: sitting and standing, with three items in each section (six items in total). The total score is calculated by measuring the distance in centimeters between the starting position (shoulder flexed 90° for forward reach and shoulder abducted 90° for side reach) and the maximum stable reach.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
WeeFIM
時間枠:Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

The WeeFIM is used to measure functional independence in activities of daily living for children aged 6 months to 12 years. It consists of 18 items covering self-care, toilet control, mobility, locomotion, communication, and social development.

A 7-level ordinal rating system ranging from 7 (complete independence) to 1 (total assistance), is used to score performance in each item. As with the FIM, the Wee- FIM consists of two dimensions: motor and cognitive.

The WeeFIM is a reliable and valid tool for assessing the functional status of children with CP.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
PEDQoL 4.0 Pediatric Quality of Life Questionnaire
時間枠:Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

The PEDQoL 4.0 Pediatric Quality of Life Questionnaire will be used. Depending on the participant's age, the child report and parent report forms will be used for children aged 7 and 8, and the child report and parent report forms for children aged 8-12. It is designed to measure core health dimensions defined by the World Health Organization (WHO). It is administered in parallel in child self-report and parent proxy report formats. The participant is asked how much of a problem each item has been in the past month.

Participants are asked to rate how problematic each item has been during the past month. Reverse scoring is applied and converted to a 0-100 scale: 0 = 100 points, 1 = 75 points, 2 = 50 points, 3 = 25 points, and 4 = 0 points. The total scale score is calculated by dividing the sum of responses by the number of items answered. If more than 50% of the items are missing, the scale score is not computed.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
Children/ Youth with Cerebral Palsy Brief (6-13 years of age)
時間枠:Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

Activity and Participation Assessment: Will be evaluated with the Brief ICF Core Set for Children and Adolescents with CP (≥6, <14 Years). Difficulty levels will be evaluated using the ICF Qualifiers. A score of 0 indicates no difficulty (0-4%), 1 mild difficulty (5-24%), 2 moderate difficulty (25-49%), 3 severe difficulty (50-95%), and 4 complete difficulty (96-100%). Scores 8 ("not specified") and 9 ("not applicable") are used when relevant.

Activity and participation will be assessed under the domains of performance and capacity. Higher scores in each parameter indicate greater limitation.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディチェア:Ayse R Aydin, MD, Prof.、Istanbul University Istanbul Medical Faculty, Department of Physical Medicine and Rehabilitation

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年11月20日

一次修了 (実際)

2026年8月7日

研究の完了 (実際)

2026年8月7日

試験登録日

最初に提出

2025年9月29日

QC基準を満たした最初の提出物

2025年11月16日

最初の投稿 (実際)

2025年11月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月22日

QC基準を満たした最後の更新が送信されました

2026年9月17日

最終確認日

2025年11月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する